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RESEARCH ARTICLE
The role of diseases, risk factors and symptoms in the definition of
multimorbidity – a systematic review
Tora Grauers Willadsena,b, Anna Bebea,b, Rasmus Køster-Rasmussena, Dorte Ejg Jarbølc, Ann Dorrit Guassoraa,
Frans Boch Waldorffa,c, Susanne Reventlowa,b and Niels de Fine Olivariusa,b
aThe Research Unit for General Practice and Department of General Practice, Department of Public Health, University of Copenhagen,
Copenhagen, Denmark; bThe Lolland Falster Population Study (LOFUS), Nykøbing F, Denmark; cThe Research Unit of General Practice,
Department of Public Health, University of Southern Denmark, Odense, Denmark
ABSTRACT
Objective is to explore how multimorbidity is defined in the scientific literature, with a focus on
the roles of diseases, risk factors, and symptoms in the definitions. Design: Systematic review.
Methods: MEDLINE (PubMed), Embase, and The Cochrane Library were searched for relevant pub-
lications up until October 2013. One author extracted the information. Ambiguities were resolved,
and consensus reached with one co-author. Outcome measures were: cut-off point for the num-
ber of conditions included in the definitions of multimorbidity; setting; data sources; number,
kind, duration, and severity of diagnoses, risk factors, and symptoms. We reviewed 163 articles.
In 61 articles (37%), the cut-off point for multimorbidity was two or more conditions (diseases,
risk factors, or symptoms). The most frequently used setting was the general population
(68 articles, 42%), and primary care (41 articles, 25%). Sources of data were primarily self-reports
(56 articles, 42%). Out of the 163 articles selected, 115 had individually constructed multimorbid-
ity definitions, and in these articles diseases occurred in all definitions, with diabetes as the most
frequent. Risk factors occurred in 98 (85%) and symptoms in 71 (62%) of the definitions. The
severity of conditions was used in 26 (23%) of the definitions, but in different ways. The defin-
ition of multimorbidity is heterogeneous and risk factors are more often included than symptoms.
The severity of conditions is seldom included. Since the number of people living with multimor-
bidity is increasing there is a need to develop a concept of multimorbidity that is more useful in
daily clinical work.
KEY POINTS
 The increasing number of multimorbidity patients challenges the healthcare system. The con-
cept of multimorbidity needs further discussion in order to be implemented in daily clinical
practice.
 Many definitions of multimorbidity exist and most often a cut-off point of two or more is
applied to a range of 4–147 different conditions.
 Diseases are included in all definitions of multimorbidity.
 Risk factors are often included in existing definitions, whereas symptoms and the severity of
the conditions are less frequently included.
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Introduction
The occurrence of multimorbidity (MM), which can be
defined as the co-existence in one patient of two or
more concurrent chronic conditions (e.g., diseases, risk
factors, or symptoms) is increasing.[1,2]. Even though
the prevalence increases with age, the majority of
patients suffering from MM are of working age.[3] For
society, MM results in increased costs and more
frequent hospital admissions.[4] For the individual,
mortality increases [5] and quality of life decreases
with the number of conditions.[6]
Definitions of MM are wide-ranging with conditions
varying in number, kind, and severity. Sources of data
and settings around the definitions are diverse, and
sometimes social aspects or mental health are included
in the definition.[7–9] The definition of MM is mainly
CONTACT Tora Grauers Willadsen tora.willadsen@sund.ku.dk The Research Unit for General Practice, Department of Public Health, University of
Copenhagen, Øster Farimagsgade 5, DK-1014, Post Box 2099, Copenhagen, Denmark
 2016 The Author(s). Published by Taylor & Francis. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is
properly cited.
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based on diseases.[9] In general, a disease is an entity
based on either symptoms and/or objective measures.
A disease is often labelled with a diagnosis, and the
diagnosis serves as a tool for health professionals to
communicate and find optimal treatments and solu-
tions for medical problems.[10,11] Risk factors for
developing disease, however, are also often treated as
diseases, as the purpose of paying attention to a risk
factor is to create the basis for actions from the patient
and the doctor to prevent disease.[12,13] Symptoms
may be defined as ‘‘any expression of disturbed func-
tion or structure of the body and mind by a
patient’’,[14] and the patient’s interpretation of the
intensity and the presumed danger of symptoms is
central to decisions about if and when a doctor is con-
sulted.[15,16] Diseases and risk factors can sometimes
be less meaningful to patients since they do not
always explain co-occurring symptoms.[17]
Furthermore, a diagnosis, whether it comes from a dis-
ease or a risk factor, can lower self-rated health [18]
and the relevance of becoming labelled with MM
when only suffering from risk factors is questionable.
On the other hand, symptoms cannot always be
explained and can contain more dimensions of the
human mind than strictly medical.[19] This means that
substantially different aspects of health are included in
definitions of MM. Existing MM definitions may seem
more suitable for epidemiological research than for
clinical work. In the light of the increasing prevalence
and burden of MM, definitions which are more useful
in daily practical work could be more helpful for both
clinicians and patients.
The aim of this study was to review the literature
on MM in order to examine how it is defined: What
diseases, risk factors, and symptoms are included in
the definition? Are the duration and severity of condi-
tions considered? Are complications to a disease
included together with this disease in the definition of
MM or are they included as separate disease catego-
ries, e.g., retinopathies in the course of diabetes? Is
clustering considered, e.g., the likelihood of conditions
to appear together?
Methods
The review process was conducted according to
PRISMA guidelines.[20]
Search strategy
A literature review was conducted in MEDLINE
(PubMed) and Embase. The databases were searched
up until 4 October 2013 (protocol can be forwarded
on request). We applied the search string with different
linguistic variations of the terms multimorbidity and
comorbidity, and also with related synonyms, in order
to increase sensitivity, i.e., the chance of finding articles
considering MM without using the term itself. Since
the word ‘‘multimorbidity’’ does not exist as a MeSH-
term (Medical Subject Heading) in MEDLINE, we
searched for it as a keyword. We searched for comor-
bidity both as a MeSH-term and as a keyword. The
search was restricted to research on humans, in the
English language, and articles with available abstracts.
In addition, the same search was performed in The
Cochrane Library up until 10 October 2013, but with-
out restrictions. After exclusion of irrelevant references
and removal of duplicates, no references remained
from The Cochrane Library. One author (TGW) per-
formed and conducted the search. For the search in
MEDLINE (Box 1).
Selection of studies
After removal of duplicates, one author (TGW) screened
all titles and abstracts for relevance. The eligibility of
potentially relevant articles was assessed in full text (by
TGW). For inclusion in the final synthesis, the articles
had to be empirical and contain a definition of MM.
Systematic reviews and theoretical articles were
excluded because they mainly summarized the work of
others without creating their own definitions (Figure 1).
Since the aim of this study was to describe how MM is
defined, we did not assess the quality of the articles
included. Reference lists for all eligible articles and the
systematic reviews that were excluded were searched
by title for further articles. The first author (TGW)
extracted data items into a pre-specified table. The fol-
lowing items were extracted: cut-off point in the num-
ber of conditions in the definition of MM, population
size, setting, sources of data, the number and kind of
conditions included, risk factors, symptoms, complica-
tions, duration of the conditions, considerations of clus-
tering between conditions, and finally considerations
Box 1. Results of search strategy in MEDLINE.
#1,"Search (comorbidity AND ""multiple chronic disorders"")", 0
#2,"Search (comorbidity AND ""multiple chronic diseases"")", 30
#3,"Search (comorbidity AND ""multiple chronic conditions"")", 70
#4,"Search (co-morbidity AND ""multiple chronic disorders"")", 0
#5,"Search (co-morbidity AND ""multiple chronic diseases"")", 31
#6,"Search (co-morbidity AND ""multiple chronic conditions"")", 74
#7,"Search multi-morb*", 174
#8,"Search multimorb*", 1076
#9, ‘‘#1OR#2OR#3OR#4OR#5OR#6OR7#OR#8’’, 1313
#10, ‘‘#9, with Filters: Abstract available", 1204
#11, ‘‘#9, with Filters: Abstract available, Humans", 984
#12, ‘‘#9, with Filters: Abstract available, Humans, English", 588
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about and measurement of the severity of conditions
included. (The full document and the references of all
163 articles included in our study are available as an
electronic appendix 1 and 2 at http://almenpraksis.ku.
dk/english/research/appendix_1.pdf/ and at http://
almenpraksis.ku.dk/english/research/appendix_2.pdf/
Ambiguous findings that emerged after titles and
abstracts were screened, and then read in full text, were
discussed and resolved with one of the co-authors
(NdFO).
Definition of diseases, risk factors and symptoms
Diseases were defined based on the assumption that
they were health conditions diagnosed by objective
measures, symptoms or both, and that a distinct diag-
nostic code exists to describe them. Risk factors were
defined as conditions or measurements associated
with the probability of disease or death [21,22] not
necessarily recognised by the patient. Symptoms were
defined by using ICPC’s definition of symptoms.[23]
Results
Of 248 articles screened, we included 163 in our study
(Figure 1). The majority of these articles were observa-
tional and only three were randomized controlled
trials.
Definition of MM, population size, setting, and
data sources
Of the 163 articles we selected, 61 (37%) used a
cut-off point of two or more conditions in their
definition of MM (i.e., diseases, risk factors, and
symptoms); four (2%) used a cut-off point of one
condition, and 11 (7%) used a cut-off point of
three conditions. Thirteen articles (8%) had several
cut-off points, 19 (12%) used different MM-indices
without a specific cut-off, while 55 (34%) did not
specify cut-offs at all.
The population size varied considerably in the
selected articles. Twenty-four articles (15%) had
Matches identified through database searching 
in Embase (n=982) and PubMed (n=588) on the 
4th Oct 2013.  
Abstracts and titles screened (n=943) 
Articles assessed for full text reading (n=248) 
Articles meeting inclusion criteria (n=150) 
Excluded articles (n=695):
Not addressing multimorbidity or comorbidity (n=390)  
Exclusively considering comorbidity indices or comorbidity 
(n =8) 
Exclusively addressing psychiatric comorbidities (n = 12) 
Considering a specific disease/particular combinations of 
diseases (n = 161) 
Population aged under 18 years (n = 5) 
Conference abstracts (n=80) 
Qualitative studies (n = 35) 
Other language than English (n=4) 
Duplicates removed (n=627)
Excluded articles (n= 98): 
Not stating a definition of multimorbidity (n =32)  
Systematic reviews or reviews (n=26) 
Theoretical/methodological articles (n=26) 
Dealing with co-morbidity only (n=9) 
Editorial or commentary (n=4) 
Already included in another article (n=1) 
Additional articles from searching cross-references (n=13) 
Articles included in the review (n=163) 
Articles presenting specific types and numbers 
of conditions (n=115) 
Articles using multimorbidity indices (n=30) 
Insufficient information on types and numbers 
of conditions (n=21) 
Figure 1. Flow-chart describing the selection of studies.
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>100.000 participants and 48 (29%) had <1000 partici-
pants, with a range from 38 patients in the smallest to
approximately 31 million in the largest. Participants
were mainly recruited from the general population (68
articles, 42%), while many came from primary care (41
articles, 25%), and some from secondary care (16
articles, 10%). In one article, participants were recruited
from a nursing home,[24] and in 26 articles (16%) they
came from specific databases, for example veter-
ans,[25] twins,[26] or employees.[27] Eleven articles
(7%) included people from several settings simultan-
eously. Data were from self-reports (56 articles, 34%),
registries (36 articles, 22%), medical records (22 articles,
13%), clinical examinations (3 articles, 2%), and medica-
tion data (2 articles, 1%). Finally, 44 articles (27%) had
data from several sources concurrently.
Of the 163 articles included in our study, 115
(71%) used individually constructed definitions of MM
and only a handful of the articles used an existing
definition. The results of the 115 articles are pre-
sented below. Thirty articles (18%) defined MM using
either existing morbidity indices, which were not ori-
ginally designed to rate MM, or a clinical database of
ICPC codes (see below). Three articles were included
in two categories: as an individually developed defin-
ition and as an index. These articles used an index
but explicitly selected some of the conditions from
the index in question, indicating a process of reflec-
tion when defining MM (see electronic appendix 1).
Finally, 21 articles (13%) presented insufficient infor-
mation about types of conditions, or did not select
the conditions in advance, and they are not reported
upon here.
In the 115 articles that used individually constructed
definitions of MM, the pool of conditions to choose
from varied from 4 [28] to 147.[29] The conditions
included were primarily chronic as defined by WHO:
‘‘health problems that require on-going management
over a period of years or decades’’.[30] Other defini-
tions were also used, e.g., if the condition was pre-
sumed permanent or caused by pathological
alterations without chance of reversibility.[31]
Diseases
All 115 articles reported information on diseases. Some
included clear diagnostic entities such as myocardial
infarction,[32] while others included broader diagnostic
groups like heart disease.[33] Diabetes, stroke, and can-
cer were the most frequently occurring diseases (Table
1). Fibromyalgia, sexually transmitted diseases, para-
sites, and infections were the least frequently occurring
diseases.
Risk factors
Ninety eight articles (85%) included one or more of
the following risk factors: hypertension, osteoporosis,
hypercholesterolemia, obesity, and overweight (Table
1). Risk factors were included in the definitions in the
same way as diseases with one risk factor representing
one condition.
Symptoms
Seventy one articles (62%) reported information on
symptoms. As for diseases and risk factors, one symp-
tom represented one condition. The most frequently
occurring symptom was back pain, followed by visual
impairment, and urinary incontinence (Table 1). Several
symptoms occurred in only one definition, e.g., itching,
nausea, dysphagia, diarrhea and abdominal pain.
The role of duration, severity, clustering of
conditions, and occurrence of complications
The duration of a condition was explicitly mentioned
and specified as an inclusion criterion for the definition
of MM in 32 of the 115 articles (28%). However, when
used, duration was operationalized in many different
Table 1. Most prevalent diseases, risk factors and symptoms in
the definition of multimorbidity in the 115 articles.
Most prevalent conditions Number of articles Frequency (%)
Diseases
Diabetes 112 97
Stroke 92 80
Cancer 91 79
Ischemic heart disease
(incl. MI and angina)
81 70
COPD 73 63
Heart failure 70 61
Asthma 66 57
Depression 58 50
Kidney disease 52 45
Osteoarthritis 50 43
Risk factors* 98 85
Hypertension 91 79
Osteoporosis 43 37
Hypercholesterolemia 34 30
Obesity 28 24
Overweight 7 6
Symptoms 71 62
Back pain 32 28
Visual impairment 25 22
Urinary incontinence 16 14
Alcohol disorder/abuse 16 14
Hearing impairment 14 12
GI-problems 11 10
Headache 14 12
Dizziness 13 11
Tobacco abuse 9 8
Sleeping disorders (incl. insomnia) 8 7
*Only five risk factors are included in the MM-definitions.
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ways by, for instance, including only conditions present
during the last year, or using more specific time limits
for certain conditions, such as excluding cancer diag-
nosed more than 5 years before the study (Table 2).
Severity was included to some extent in 26 of the
articles (23%). It varied from patients’ self-reported
severity of a condition, to only including diseases with
defined severity stages, e.g., heart failure with at least
NYHA II (New York Heart Association functional classifi-
cation, stage 2). Considerations on how conditions are
clustered in the individually constructed MM defini-
tions were only apparent in a few articles. These
mainly described conditions within different organ
groups, or they grouped conditions with the same
pathophysiological mechanisms. However, considera-
tions of clustering did not influence the results since
most of the conditions were not reported upon as a
group but as separate diagnoses. Complications were
in general not stated as such even though, for
example, renal failure that could be considered a com-
plication of diabetes was included in some definitions
of MM. Therefore, information on clustering and com-
plications could not be summarised.
Multimorbidity indices
Almost all indices include diseases. The Adjusted
Clinical Groups (ACG) Case Mix System and its sub-
groups, Aggregated Diagnosis Groups (ADG),
Medication-based Rx-MG, Expanded Diagnosis Clusters
(EDC), and Resource Utilization Bands (RUB) almost all
contain information on both risk factors and symp-
toms. Severity is also included in most ACG subgroups
(Table 3). For Clinical Classifications Software (CCS), risk
Table 2. Every aspect of duration mentioned in the 115 articles.
Author, publication year Disease Duration
Agborsangaya, 2013 All Health status the past 12 months.
Alonso, 2004 Ischemic heart disease Last year
Andrade, 2010 Psychiatric disorders ‘‘. . .felt for a period longer than two weeks. . .’’ and ‘‘have you had
feelings of anxiety and tension for more than one month’’.
Ataguba, 2013 Illness
Disabilities
1 month
6 months
Barnett, 2012 Any kind For prescriptions >12 months
Bayliss, 2004 Myocardial infarction
Angina
Within the past 6 months and more than 1 year ago
History
Bayliss, 2005 Cancer
All (except cancer)
Past 5 years
Two years before
Bernabeu-Wittel, 2009 Chronic renal disease Creatinemia or proteinuria for at least 3 months
Bernabeu-Wittel, 2011 Chronic renal disease Creatinemia or proteinuria for at least 3 months
Bernabeu-Wittel, 2011 Chronic renal disease Creatinemia or proteinuria for at least 3 months
Cheung, 2013 Malignancy Within 5 years
Diederichs, 2012 All Occurrence the last 5 years
Drewes, 2011 Depressive symptoms
Cancer and myocardial infarction
Previous year
History
Fried 2012 All
Asthma
‘‘Have you ever been told by a doctor?’’
During the past 12 months have you had an episode of asthma?
Fuchs, 2012 All
Cancer
Chronic back pain
Ever told by a physician and present the last 12 months
Life time medical history
At least 3 months the last 12 months
Grimby, 1997 Knee joint disorders, hip joint disorders and
upper extremity disorders
More than 6 months
Gunn, 2012 All Experienced the disease in the last 12 months
Haggerty, 2010 Cancer Past 5 years
Hunger, 2011 All
Sputum for chronic bronchitis
Ever had
3 months
H€arter, 2007 All Present within the previous 12 months.
Marengoni, 2008 Malignancy Anamnestic and current
Marengoni, 2008 Malignancy Anamnestic and current
Marin-Ruiz, 2011 Cancer Diagnosed within past 5 years.
McDaid, 2013 All Present the previous year.
McRae, 2013 All More than 6 months.
Menotti, 2001 COPD Productive cough for at least three months
Neeleman, 2001 All Experienced the previous 1 year
Neeleman, 2002 Psychiatric symptoms Present during the preceding year
Payne, 2013 Based on prescription
Cancer
12 months
Last 5 years
Rincon-Gomez, 2011 Chronic renal disease Creatinemia or proteinuria for at least 3 months
Salive, 2013 All 1, 2, or 3 years, depending on condition
Schneider, 2009 Cancer, COPD, depression
Chronic kidney disease, diabetes, heart failure
1-year look back period
2-years look back period
van Oostrom, 2012 All Registered with the condition in 3 consecutive years.
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factors and symptoms are included in the index, but
not severity. The Cumulative Illness Rating Scale (CIRS),
which includes diseases from 13 different organ sys-
tems, does not specify whether risk factors or symp-
toms are included but it places severity at the centre
of the index (with rating of every condition on a four
grade scale). Charlson Comorbidity Index (CCI) includes
some symptoms and rates severity to some extent, but
contains no risk factors. Systems such as the Quality
and Outcomes Framework (QoF) and The Functional
Comorbidity Index (FCI) include risk factors and symp-
toms but do not consider their severity. The Index of
Coexistent Disease (ICED), on the other hand, contains
both risk factors and severity, but has no symptoms.
Finally a Dutch database, The Registration Network
Family Practices (RNH) includes risk factors, but neither
symptoms nor severity. Some articles that used an
index did not explicitly mention if they used all condi-
tions included in the index or just a selection.
Discussion
We found great heterogeneity in the definition of MM
and the pool of conditions to choose from varied from
4 to 147. Most often a cut-off point of two or more
conditions was used to define MM. Diseases were
used in all definitions, and the most common were
diabetes, stroke, cancer, ischaemic heart disease, and
COPD (Table 1). Risk factors were included in 85% of
the individually developed definitions of MM and in all
indices except CCI. Two further indices gave inad-
equate information (Table 3). Hypertension was the
most frequent risk factor and was included to the
same degree as a cancer diagnosis in MM definitions.
Other risk factor-based conditions were osteoporosis,
hypercholesterolemia, obesity, and overweight (Table
1). Symptoms were included in 62% of the articles
with great diversity regarding the types of symptoms.
The most frequent symptoms were back pain, visual
impairment, urinary incontinence, alcohol disorder, and
hearing impairment (Table 1). Duration was mentioned
in 28% of the articles (Table 2) and, to some extent,
the severity of conditions was included in 23% of the
articles.
The role of diseases
Diseases are included in all definitions of MM.
However, they do not always explain the patient’s
experience of symptoms, and patient needs and symp-
tom experience are not necessarily an indication of an
underlying disease. Relying only on diseases when
Table 3. Multimorbidity indices and databases used in 30 articles out of the total of 163 articles.
Index Classification codes Outcomes of interest Number of diseases
Risk factors
included
Symptoms
included
Severity
included
The Charlson Comorbidity
Index (CCI)
ICD, ICPC or self-
reports
Mortality 19 (17 in modified version) No Yes Yes
Clinical Classification Software
(CCS)
ICD-9-CM (5-digit
codes)
Cluster diagnoses and proce-
dures in clinically meaningful
categories
14,000 codes grouped in 285
diagnose categories and 231
procedure categories
Yes Yes No
Cumulative Illness Rating
Scale (CIRS) and geriatric ver-
sion (CIRS-G)
ICD, ICPC and self-
reports
Physical impairment 13 body systems (14 in CIRS-
G)
Not specified Not specified Yes
Adjusted Clinical Groups
(ACG-Case Mix System)
ICD-9 and -10 Health care utilization and
costs
25,000 diagnoses and 3900
procedures
Yes Yes Yes
Aggregated diagnosis groups
(ADG)*
ICD-9, 9-CM and -10 Health care use The 25,000 diagnoses divided
in to 32 diagnostic clusters
Yes Yes Yes
Medication-based Rx-MG* US NDC codes and
Anatomical
Therapeutic Chemical
(ATC) system codes
Medical and total health care
costs
19 major Rx-MG categories Not stated Yes Not stated
Expanded Diagnosis Clusters
(EDC)*
ICD-9, -9-CM and -10 Identifying people with spe-
cific symptoms and diagnoses
264 EDC further divided in 27
Major Expanded Diagnosis
Clusters (MEDCs)
Yes Yes No
Resource Utilization Bands
(RUBs)*
IC-9 and -10 Predict resource use Four categories RUB 0 (No
resource use)-RUB 3 (High
expected costs)
Yes Yes Yes
The Functional Comorbidity
Index (FCI)
Self-reports Physical function 18 conditions Yes Yes No
The Index of Coexistent
Disease (ICED)
Self-reports and
laboratory tests
Comorbidity severity 13 disease categories with 17
conditions and 11 domains of
physical impairment
Yes No Yes
Quality and Outcomes
Framework (QoF)
Read codes For payment and performance
of GPs
17 conditions Yes Yes No
The Registration Network
Family Practices (RNH)
ICPC To identify health problems
and combinations of health
problems
335 chronic diagnostic catego-
ries (database includes 700)
Yes No No
*Based on ACG-Case Mix System
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defining MM may lead to a concept that does not
reflect patients’ perspectives. Previously, diabetes has
been found to be the most frequent disease in the
definition of MM, followed by stroke, cardiovascular
disease, hypertension, and cancer.[9] We identified a
similar pattern, even though we found that cancer was
used more often than cardiovascular disease. This
could be due to different ways of defining cardiovascu-
lar disease.
The role of risk factors
Risk factors, based on objective rather than subjective
measures, are easy to quantify [34] and therefore
easy to use in epidemiological research. Hypertension
and hyperlipidaemia were observed as the most
prevalent conditions in a population study that
included almost 31 million Americans.[35] Similarly, in
other studies in different settings and countries,
hypertension is reported as the most prevalent
chronic condition.[36,37] We found this mirrored in
the definitions of MM as well. One systematic review
found that prevalence was the main reason for
including conditions in MM.[9] Nevertheless, condi-
tions that are common in the population, like aller-
gies and hypertension, are not necessarily those with
the largest impact on patients’ functional status or
quality of life.[38] Furthermore, the burden of illness
reported by patients is lower among those having
hypertension compared to patients with other condi-
tions.[37] If relying too much on risk factors when
defining MM, the MM measure will probably become
too coloured by aspects concerning awareness of
future illness, rather than the actual disease burden
or functional status.
The role of symptoms
Symptoms are generally the focus of patients’ concerns
and are dependent on the experiences and history of
the patient and often the reason for contacting a doc-
tor. For the doctor, the symptom and what the patient
presents are central for the diagnostic process and the
doctor grades according to importance and frames
what the patient says.[39] Headache and back pain
seem to be the most debilitating symptoms among
people who report poor self-rated health,[40] and back
pain is reported as among the most prevalent condi-
tions in all age groups.[41] Furthermore, symptoms are
an important factor for mortality in line with dis-
eases.[42] In this review, we found that symptoms
occur less frequently in the definition of MM than risk
factors.
Relation to other studies
Since useful clinical guidelines for patients with MM
are scarce it was expected [43] that only a minority of
the articles found in the literature search were
randomized controlled trials. Furthermore, randomized
controlled trials involving primary care patients rarely
report whether patients with coexisting conditions are
excluded or not, and if they are included only few con-
ditions are considered.[44] Pharmaceutical trials often
have many exclusion criteria for chronic conditions
compared to observational studies.
The considerable variability in the prevalence of MM
between studies may have several explanations. First,
the setting is important. MM is obviously very common
in nursing homes, and patients recruited in family prac-
tice are more likely to have more conditions compared
to those recruited in the general population.[45]
Second, MM increases with the range of conditions
included in the definition.[8] Third, the longer the
observation period, the more conditions and clusters of
diagnoses are captured.[46] Fourth, sources of data can
affect prevalence. Prevalence is higher when more con-
ditions are considered or when the cut-off of two or
more conditions is used instead of a higher cut-off.
Furthermore, the prevalence of MM rises when condi-
tions are counted as single diseases with a unique diag-
nosis code instead of being included in the group of
codes (often organ system) the condition belongs
to.[47] On the other hand, complexity of the conditions
and also health care use are dependent on if conditions
are concordant or discordant, i.e. have the same patho-
physiology with equal management or not [48] and
conditions that cluster tend to be more concordant.
Within the last 5 years, there have been several sys-
tematic reviews on MM. Their focus has varied from
occurrence, patterns, and consequences of
MM,[8,49,50] to interventions,[51] functional status,[52]
self-management,[53] and implementation of care pro-
grams.[54] One review focused on measures of disease
burden and found indices like CCI, CIRS, and ACG
System useful depending on the outcome of inter-
est.[55] We found 30 articles that used indices for
measuring MM. Indices of MM may be better than sim-
ple counts of conditions to detect certain circumstan-
ces that are important for the patient, such as
psychological distress.[56] This is because some indices
allow important information from the text of the med-
ical record to be included with diseases. However,
prevalence estimates using either chapters in ICPC,
ICD-10, or CIRS have shown to be comparable.[47]
To the best of our knowledge, only two reviews
have studied the definition of MM until now. In 2009,
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Diederichs et al. collected information on the number
and type of conditions from 39 selected articles.[9] As
in the present review, they found great heterogeneity
between studies in the type of conditions that could
account for MM and they highlighted the need for a
uniform way to estimate MM. In 2013, Le Reste et al.
suggested a comprehensive definition of MM specific-
ally suited to primary care. Based on a selection of 54
qualitative articles, they concluded: ‘‘MM is defined as
any combination of chronic disease with at least one
other disease (acute or chronic) or biopsychosocial fac-
tor (associated or not) or somatic risk factor’’. In
accordance with our findings, all definitions of MM
contained several chronic diseases. Thus, while it
seems meaningful to include at least one chronic con-
dition as Le Reste et al. suggest, we found that acute
conditions are very rarely included. In some specialties
one chronic condition could be meaningful in the co-
occurrence of an extra acute condition, e.g., diabetes
in a surgical patient. However, for general practice
where the acute complaints can be less severe the
importance of this way of defining MM can be less
clear, especially if we will use MM prevalence to plan
healthcare.[47] Including biopsychosocial factors opens
up the possibility of including symptoms, which is one
way of integrating patient perspectives in MM-defini-
tions, as long as a symptom is not classified as a
chronic condition and already included. Thus, Le Reste
et al. consider disease burden, risk factors, social net-
work etc. to be modifiers of the effects of MM [7] and
their definition may better reflect daily clinical work in
general practice in comparison with counting diseases.
By including the disease burden, they also consider
the severity of the conditions, which we found
included in only a quarter of the articles we selected.
While we found risk factors to be one of the most
important features of the MM definition to date, Le
Reste et al. maintain that risk factors only contribute to
the definition of MM when they occur in combination
with other chronic conditions, implying that risk factors
alone cannot lead to MM. Further, Le Reste et al.
include social networks as modifiers which seems
meaningful since the contextual factors surrounding a
patient are sometimes as important as a disease.[57]
However, operationalization of social factors is difficult.
While patients can have a large social network, support
from it can be of low quality, and religious beliefs or
cultural traditions can give patients obligations that are
difficult to capture in a definition. Furthermore, the
point in time to concentrate on a problem can be
more important than the diagnosis itself. For example,
a diagnosis made 5 years ago is often not the focus of
concern any more.[58]
Limitations and strengths
The objective of this study was to shed light on the
diversity of definitions of MM. It is possible, however,
that our search strategy has overlooked important
articles having a unique definition, and in this context
the lack of a MeSH-term for MM was a limitation. We
compensated for this by choosing a broad search strat-
egy with several linguistic variations of MM to increase
sensitivity. Furthermore, there was only one reader
making the selection of articles, but even minor incon-
sistencies were settled in consensus between two
authors. We could have included languages other than
English in our study, but a substantial number of the
selected articles came from authors whose mother
tongue is not English. Therefore, we believe our find-
ings are not restricted to English-speaking countries. A
major strength of the current review is the thorough
systematic work in accordance with PRISMA-guidelines.
We therefore expect that most of the existing defini-
tions of MM were detected and included.
Clinical implications
The increase in MM is consistent between countries
and one study examining the development of MM
over the last 20 years found the largest increase in MM
prevalence for those with four or more conditions.[2]
MM accounts for many consultations in primary care.
The number of conditions is associated with the num-
ber of consultations [4] and is inversely associated with
continuity of care.[59] Furthermore, when defining MM
as two or more conditions almost half of the patients
in primary care are multimorbid [47] and this will
become even more pronounced in the future.
However, counting diseases and mapping patterns are
maybe of less relevance compared to the disability
connected with and the severity of the conditions,[52]
also because interventions for MM have shown to be
most effective when focusing on functional difficulties
rather than the individual diseases.[51] There is a need
to discuss definitions of MM that are more relevant for
daily clinical work with patients, and that have a better
capability of capturing the patient’s perspective. These
definitions can help us identify MM where it is impera-
tive to treat, and MM where the best solution may be
not to treat. Based on qualitative data, Le Reste et al.
[7] have given the most inspiring and comprehensive
definition of MM so far, one that is particularly suited
to primary care. Since this review has explored the role
of symptoms and risk factors in the definition of MM,
it can make a valid contribution to the discussion of
future definitions of MM.
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Conclusion
In line with earlier research, this review of 163 articles
shows a large variation in the number and types of
conditions that are included in the definition of MM,
which consist mainly of diseases. The fundamental role
of risk factors in the definition of MM is one reason for
the high prevalence of MM. Symptoms and severity
are included less often and this contributes to making
the existing definitions more usable for epidemiolo-
gists than for clinicians and patients. This review adds
to the discussion about more comprehensive and clin-
ically relevant MM definitions.
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